130
Views
8
CrossRef citations to date
0
Altmetric
Short Reports

Radionecrosis following gamma knife treatment for mesial temporal lobe epilepsy

&
Pages 649-651 | Received 01 Nov 2010, Accepted 30 Dec 2010, Published online: 18 Apr 2011
 

Abstract

A 24-year-old male patient was treated with Gamma Knife surgery (GKS) for medial temporal lobe epilepsy. The treatment parameters were in accordance with established practice. Epilepsy stopped after 2 years and medication was discontinued. Four years later, he developed a profound radionecrosis leading to blindness. As had refused surgical intervention his blindness has become permanent. As this is the second such case to be reported, it is considered a cause for concern, since microsurgery remains a safe alternative treatment. It is suggested that GKS for mesial temporal lobe epilepsy should be restricted to University centres of excellence as part of research projects under the control of ethics committees. It should not at present be considered to be a safe treatment for general use.

Acknowledgement

The authors would like to acknowledge the assistance of Dr. Ahmed Gaber who referred the patient and who managed his epilepsy.

Declaration of interest:

Dr. Ganz is a consultant for Elekta, Stockholm, the manufacturer of the Gamma Knife. Dr. Reda has no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.